US Patent 10010533 Formulations of bendamustine
Patent 10010533 was granted and assigned to Eagle Pharmaceuticals, Inc. on July, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10010533 Formulations of bendamustine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.